Image-Guided Radiotherapy and Chemotherapy in Gynaecological Cancer

FIGO staging 2008

5-year survival: 89.1%

Stage I: confined to cervix – Ia1: minimal microscopic invasion – Ia2: invasion ≤ 5mm depth and ≤ 7mm horizontally – Ib1: greater than Ia, clinically visible, confined to the cervix, ≤ 4 cm size – Ib2: > 4 cm size

•

5-year survival : 75.7%

• Stage II: invades beyond cervix but not to side wall or lower third of vagina – IIa: tumour without parametrial invasion

• IIa1: ≤ 4 cm size • IIa2: > 4 cm size – IIb: tumour with parametrial invasion

• Stage III: tumour extends to pelvic sidewall and/or lower third of vagina or causes hydronephrosis or non-functioning kidney

– IIIa: lower third of vagina, no pelvic side wall extension – IIIb: involving pelvic side wall or causing hydronephrosis

• Stage IV: tumour invades mucosa of bladder or rectum and/or extends beyond true pelvis